Log in to save to my catalogue

Chimeric Antigen Receptor-Natural Killer Cells: The Future of Cancer Immunotherapy

Chimeric Antigen Receptor-Natural Killer Cells: The Future of Cancer Immunotherapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6735593

Chimeric Antigen Receptor-Natural Killer Cells: The Future of Cancer Immunotherapy

About this item

Full title

Chimeric Antigen Receptor-Natural Killer Cells: The Future of Cancer Immunotherapy

Publisher

New Orleans: Ochsner Clinic Foundation Academic Center - Publishing Services

Journal title

The Ochsner journal, 2019-01, Vol.19 (3), p.186-187

Language

English

Formats

Publication information

Publisher

New Orleans: Ochsner Clinic Foundation Academic Center - Publishing Services

More information

Scope and Contents

Contents

NK cells have spontaneous cytotoxic activity and can generate target cell death independent of tumor antigen, while T lymphocytes only kill their targets by a CAR-specific mechanism. [...]in the setting of antigen downregulation by tumor cells attempting to escape immune detection, NK cells would still be effective against tumor cells. Individual N...

Alternative Titles

Full title

Chimeric Antigen Receptor-Natural Killer Cells: The Future of Cancer Immunotherapy

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6735593

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6735593

Other Identifiers

ISSN

1524-5012

E-ISSN

1524-5012

DOI

10.31486/toj.19.0033

How to access this item